Found 19 matching trials
Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation
PHASE1The recent introduction of ex-vivo lung perfusion (EVLP) as a tool to evalu...
Location
Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico
Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System⢠at a Dedicated EVLP Facility
NAThis is a safety study to compare the safety of receiving a lung treated wi...
Location
Mayo Clinic Jacksonville
BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction
EARLY_PHASE1This study will determine if primary graft dysfunction (which causes low bl...
Location
Northwestern University
Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial
PHASE1Post-transplant lymphoproliferative disorders (PTLD) can present as a type ...
Location
University Health Network, Toronto General Hospital, Multi-Organ Transplant
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
NAHuman donor lungs that do not meet the standard clinical criteria for donor...
Location
Cedars-Sinai Medical Center
Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation
PHASE1The use of ex vivo lung perfusion (EVLP) will allow for a secondary evaluat...
Location
Toronto General Hospital
The University of Alberta Negative Pressure Ventilation Ex-Vivo Lung Perfusion (NPV-EVLP) Trial
NAThis project is focused on helping one of the most vulnerable patient popul...
Location
University of Alberta Hospital
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
NAThe purpose of this research study is to perfect the technique of EVLP and ...
Impact of the Ex-vivo Pulmonary Perfusion System on the Microbiome of Lung Grafts and Their Inflammatory Reaction.
NAIt is known that the interactions of the graft and recipient microbiome are...
Location
Hospital ClĂnic de Barcelona
Transplantation Using Hepatitis C Positive Donors, A Safety Trial
PHASE3The success of transplantation is significantly hindered by the lack of suf...
Location
University Health Network Toronto General Hospital